prospective Evaluation of the in - vitro Platelet function as well as the concentration of platelets in the cerebrospinal fluid in patients with aneurysmal SAH

prospective Evaluation of the in - vitro Platelet function as well as the concentration of platelets in the cerebrospinal fluid in patients with aneurysmal SAH - PlaFuSah Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009244

Enrollment

350

Registered

2015-08-26

Start date

2015-08-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I60

Interventions

Group 1: Platelet function will be determined using the PFA 100 test in patients with aneurysmal subarachnoid haemorrhage at different time points as well as on days with clinical or radiological evid

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years; aneurysmal SAH; informed consent (if patient is not conscious - a custodian will be determined by the responsible legal institution); primary SAH; Aneurysm closure < 48 hours after rupture

Exclusion criteria

Exclusion criteria: non - aneurysmal SAH; fisher °I ( no SAH visible on primary cranial CT Scan); pregnancy; life expectancy < 1 year

Design outcomes

Primary

Measure	Time frame
DCI („delayed cerebral ischemia“) in the first 6 weeks	—

Secondary

Measure	Time frame
outcome after 6 weeks: degree of disability after a stroke, using mRS (Modified Rankin Scale)	—

Countries

Germany

Contacts

Public ContactChristian von der Brelie

Neurochirurgie Universitätsklinik Kiel

christian.vonderbrelie@uksh.de00494315974801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026